These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
339 related articles for article (PubMed ID: 28836947)
1. Country and regional variations in purchase prices for essential cancer medications. Cuomo RE; Seidman RL; Mackey TK BMC Cancer; 2017 Aug; 17(1):566. PubMed ID: 28836947 [TBL] [Abstract][Full Text] [Related]
2. Access to Cardiovascular Disease and Hypertension Medicines in Developing Countries: An Analysis of Essential Medicine Lists, Price, Availability, and Affordability. Husain MJ; Datta BK; Kostova D; Joseph KT; Asma S; Richter P; Jaffe MG; Kishore SP J Am Heart Assoc; 2020 May; 9(9):e015302. PubMed ID: 32338557 [TBL] [Abstract][Full Text] [Related]
3. Comparison of Prices and Affordability of Cancer Medicines in 16 Countries in Europe and Latin America. Moye-Holz D; Vogler S Appl Health Econ Health Policy; 2022 Jan; 20(1):67-77. PubMed ID: 34228312 [TBL] [Abstract][Full Text] [Related]
4. Availability, Price and Affordability of Anticancer Medicines: Evidence from Two Cross-Sectional Surveys in the Jiangsu Province, China. Zhu Y; Wang Y; Sun X; Li X Int J Environ Res Public Health; 2019 Oct; 16(19):. PubMed ID: 31623326 [TBL] [Abstract][Full Text] [Related]
5. Baseline assessment of WHO's target for both availability and affordability of essential medicines to treat non-communicable diseases. Ewen M; Zweekhorst M; Regeer B; Laing R PLoS One; 2017; 12(2):e0171284. PubMed ID: 28170413 [TBL] [Abstract][Full Text] [Related]
6. Availability, prices, and affordability of selected essential cancer medicines in a middle-income country - the case of Mexico. Moye-Holz D; Ewen M; Dreser A; Bautista-Arredondo S; Soria-Saucedo R; van Dijk JP; Reijneveld SA; Hogerzeil HV BMC Health Serv Res; 2020 May; 20(1):424. PubMed ID: 32410676 [TBL] [Abstract][Full Text] [Related]
7. Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis. Cameron A; Ewen M; Ross-Degnan D; Ball D; Laing R Lancet; 2009 Jan; 373(9659):240-9. PubMed ID: 19042012 [TBL] [Abstract][Full Text] [Related]
8. Analysis of prices paid by low-income countries - how price sensitive is government demand for medicines? Srivastava D; McGuire A BMC Public Health; 2014 Jul; 14():767. PubMed ID: 25073407 [TBL] [Abstract][Full Text] [Related]
9. Availability and affordability of essential medicines for children in the Western part of Ethiopia: implication for access. Sado E; Sufa A BMC Pediatr; 2016 Mar; 16():40. PubMed ID: 26979737 [TBL] [Abstract][Full Text] [Related]
10. Evaluating essential medicines for treating childhood cancers: availability, price and affordability study in Ghana. Mensah KB; Mensah ABB; Bangalee V; Padayachee N; Oosthuizen F BMC Cancer; 2021 Jun; 21(1):683. PubMed ID: 34112117 [TBL] [Abstract][Full Text] [Related]
11. Prices & availability of common medicines at six sites in India using a standard methodology. Kotwani A; Ewen M; Dey D; Iyer S; Lakshmi PK; Patel A; Raman K; Singhal GL; Thawani V; Tripathi S; Laing R Indian J Med Res; 2007 May; 125(5):645-54. PubMed ID: 17642500 [TBL] [Abstract][Full Text] [Related]
12. Access to cancer medicines deemed essential by oncologists in 82 countries: an international, cross-sectional survey. Fundytus A; Sengar M; Lombe D; Hopman W; Jalink M; Gyawali B; Trapani D; Roitberg F; De Vries EGE; Moja L; Ilbawi A; Sullivan R; Booth CM Lancet Oncol; 2021 Oct; 22(10):1367-1377. PubMed ID: 34560006 [TBL] [Abstract][Full Text] [Related]
13. Access to affordable medicines after health reform: evidence from two cross-sectional surveys in Shaanxi Province, western China. Fang Y; Wagner AK; Yang S; Jiang M; Zhang F; Ross-Degnan D Lancet Glob Health; 2013 Oct; 1(4):e227-37. PubMed ID: 25104348 [TBL] [Abstract][Full Text] [Related]
14. Impact of price deregulation policy on the affordability of essential medicines for women's health: a panel data analysis. Liu J; Wang L; Liu C; Zhang X Expert Rev Pharmacoecon Outcomes Res; 2017 Dec; 17(6):625-631. PubMed ID: 28503962 [TBL] [Abstract][Full Text] [Related]
15. Prices, availability and affordability of essential medicines in rural areas of Hubei Province, China. Yang H; Dib HH; Zhu M; Qi G; Zhang X Health Policy Plan; 2010 May; 25(3):219-29. PubMed ID: 19955093 [TBL] [Abstract][Full Text] [Related]
16. Evaluating drug prices, availability, affordability, and price components: implications for access to drugs in Malaysia. Babar ZU; Ibrahim MI; Singh H; Bukahri NI; Creese A PLoS Med; 2007 Mar; 4(3):e82. PubMed ID: 17388660 [TBL] [Abstract][Full Text] [Related]
17. Pain Treatment Continues To Be Inaccessible for Many Patients Around the Globe: Second Phase of Opioid Price Watch, a Cross-Sectional Study To Monitor the Prices of Opioids. Pastrana T; Wenk R; Radbruch L; Ahmed E; De Lima L J Palliat Med; 2017 Apr; 20(4):378-387. PubMed ID: 27923102 [TBL] [Abstract][Full Text] [Related]
18. Prices of antihypertensive medicines in sub-Saharan Africa and alignment to WHO's model list of essential medicines. Twagirumukiza M; Annemans L; Kips JG; Bienvenu E; Van Bortel LM Trop Med Int Health; 2010 Mar; 15(3):350-61. PubMed ID: 20070634 [TBL] [Abstract][Full Text] [Related]
19. Pricing appraisal of anti-cancer drugs in the South East Asian, Western Pacific and East Mediterranean Region. Salmasi S; Lee KS; Ming LC; Neoh CF; Elrggal ME; Babar ZD; Khan TM; Hadi MA BMC Cancer; 2017 Dec; 17(1):903. PubMed ID: 29282008 [TBL] [Abstract][Full Text] [Related]
20. Cancer drugs in 16 European countries, Australia, and New Zealand: a cross-country price comparison study. Vogler S; Vitry A; Babar ZU Lancet Oncol; 2016 Jan; 17(1):39-47. PubMed ID: 26670089 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]